⏳ Fetching live dividend data...
Home › Calculator › BDXB Dividend Calculator 2026
Becton, Dickinson and Company · NYSE
Price: $48.16 · Annual div: $3.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in BDXB → $218.1K in 10 years · $243.02/month
Becton, Dickinson and Company (BD) is a leading global medical technology enterprise. It designs, produces, and distributes a comprehensive portfolio of medical supplies, devices, laboratory instruments, and diagnostic solutions. Its diverse customer base spans healthcare institutions, medical professionals, life science researchers, clinical laboratories, the pharmaceutical industry, and consumers worldwide. The BD Medical segment concentrates on medication management and patient care. This division delivers a broad spectrum of products, including advanced IV and catheter systems (e.g., peripheral, central, dialysis), vascular access tools, and a variety of syringes and needles for general injection, anesthesia, and diabetes care. It also provides comprehensive solutions for medication preparation and administration, such as infusion therapy systems, automated dispensing units, and inventory tracking software, along with specialized prefillable drug delivery systems. The BD Life Sciences segment is dedicated to diagnostics and research. It supplies essential products for specimen and blood collection, along with advanced diagnostic systems covering automated blood and tuberculosis culturing, molecular testing, microorganism identification, drug susceptibility analysis, and liquid-based cytology. Furthermore, this segment provides rapid diagnostic assays, microbiology automation tools, and plated media. For cellular research and specialized clinical diagnostics, it offers fluorescence-activated cell sorters and analyzers, antibodies, reagent kits, and solutions for single-cell gene expression, oncology, immunology, and transplantation monitoring. BD Interventional provides a comprehensive portfolio for surgical and specialized interventional procedures. This encompasses products for hernia and soft tissue repair, a variety of biological and bioresorbable grafts, and biosurgery solutions. The segment also offers tools for surgical infection prevention, surgical and laparoscopic instrumentation, products for peripheral vascular intervention, and essential urology and critical care items. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BDXB position with:
Real after-tax yield depends on where you live and how you hold BDXB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 6.23% | 3.43% | $623 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 5.30% | 2.50% | $530 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 4.98% | 2.18% | $498 / yr |
| 🇬🇧 UK ISA | 0% | 6.23% | 3.43% | $623 / yr |
| 🇬🇧 UK Taxable | 8.75% | 5.68% | 2.88% | $568 / yr |
| 🇨🇦 TFSA | 0% | 6.23% | 3.43% | $623 / yr |
| 🇨🇦 CA Taxable | 25% | 4.67% | 1.87% | $467 / yr |
| 🇦🇺 Super (pension) | 15% | 5.30% | 2.50% | $530 / yr |
| 🇦🇺 AU Taxable | 30% | 4.36% | 1.56% | $436 / yr |
| 🇩🇪 DE Taxable | 26.375% | 4.59% | 1.79% | $459 / yr |
| 🇫🇷 FR Taxable | 30% | 4.36% | 1.56% | $436 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $3.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
BDXB pays quarterly — 4 times per year. Next ex-div: TBD.
How BDXB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BDXB sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-09-02 | 190 | — | — | ||
| Sale | 2026-08-26 | 165 | $188.49 | $31.1K | ||
| F-InKind | 2026-08-20 | 1,049 | — | — | ||
| M-Exempt | 2026-08-13 | 43,278 | $167.25 | $7.24M | ||
| D-Return | 2026-08-13 | 39,126 | $185.00 | $7.24M | ||
| Sale | 2026-08-13 | 4,152 | $185.00 | $768.1K | ||
| M-Exempt | 2026-08-13 | 43,278 | $167.25 | $7.24M | ||
| Sale | 2026-08-11 | 2,438 | $180.84 | $440.9K | ||
| A-Award | 2026-08-06 | 189 | — | — | ||
| A-Award | 2026-08-06 | 94 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BDXB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Becton, Dickinson and Company (BDXB) is currently trading at $48.16, trading near its 52-week low. The current dividend yield is 6.23% based on an annual payout of $3.00 per share.
Becton, Dickinson and Company (BDXB) is a healthcare stock currently trading at $48.16 with a dividend yield of 6.23%. The company pays an annual dividend of $3.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, BDXB has grown its dividend at a compound annual rate of 13.5%.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever